Stockholm Stock Exchange | Large Cap
Vitrolife
+42.07%
Latest
-
3 months
CarnegieSEB EquitiesSEBHandelsbankenDNBHandelsbanken Capital MarketsDNB Markets

Price Targets For Vitrolife

AnalystPrice TargetDateUpside
Carnegie285 SEKOct -24
+42.07%
SEB Equities275 SEKOct -24
SEB275 SEKOct -24
Handelsbanken250 SEKJul -24
DNB250 SEKJul -24
Handelsbanken Capital Markets220 SEKJan -24
DNB Markets220 SEKJan -24

About The Company

Vitrolife is a Swedish medtech company which sells products for IVF treatment.
Wikipedia